$PKBK
PARKE BANCORP, INC. Stock $pkbk

$pkbk Overview Financials Valuation SEC Filings Company Website

2021 Form 10-K Financial Statement

#000131539922000039 Filed on March 21, 2022

Income Statement

Concept	2021	2020 Q4	2020
Revenue	$82.07M		$84.54M
YoY Change	-2.92%		6.28%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$687.0K	$160.0K	$586.0K
YoY Change	17.24%	45.45%	35.96%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$12.96M		$21.89M
YoY Change	-40.82%		-3.36%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$54.90M	$11.06M	$38.90M
YoY Change	41.13%	9.72%	-2.99%
Income Tax	$13.90M	$2.840M	$10.00M
% Of Pretax Income	25.32%	25.68%	25.71%
Net Earnings	$40.76M	$8.130M	$28.43M
YoY Change	43.38%	7.68%	-4.74%
Net Earnings / Revenue	49.66%		33.63%
Basic Earnings Per Share	$3.43		$2.40
Diluted Earnings Per Share	$3.36	$677.5K	$2.37
COMMON SHARES
Basic Shares Outstanding	11.89M shares	11.85M shares	11.85M shares
Diluted Shares Outstanding	12.12M shares		11.99M shares

Balance Sheet

Concept	2021	2020 Q4	2020
SHORT-TERM ASSETS
Cash & Short-Term Investments		$479.7M
YoY Change		118.66%
Cash & Equivalents		$458.6M
Short-Term Investments		$21.11M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$8.300M	$6.698M	$9.000M
YoY Change	-7.78%	-3.57%	-5.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$7.600M	$8.600M	$8.600M
YoY Change	-11.63%	36.51%	36.51%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.136B	$2.078B	$2.078B
YoY Change	2.8%	23.62%	23.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.600M	$2.300M	$2.300M
YoY Change	-30.43%	0.0%	0.0%
Accrued Expenses	$2.100M	$2.300M	$2.300M
YoY Change	-8.7%	-8.0%	-8.0%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.700M	$4.600M	$4.600M
YoY Change	-19.57%	-4.17%	-4.17%
LONG-TERM LIABILITIES
Long-Term Debt	$42.70M	$132.6M	$132.6M
YoY Change	-67.8%	889.55%	889.55%
Other Long-Term Liabilities	$11.10M	$11.40M	$11.40M
YoY Change	-2.63%	17.53%	17.53%
Total Long-Term Liabilities	$53.80M	$144.0M	$144.0M
YoY Change	-62.64%	523.38%	523.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.700M	$4.600M	$4.600M
Total Long-Term Liabilities	$53.80M	$144.0M	$144.0M
Total Liabilities	$1.904B	$1.876B	$1.877B
YoY Change	1.42%	24.9%	24.86%
SHAREHOLDERS EQUITY
Retained Earnings		$66.79M
YoY Change		51.31%
Common Stock		$1.214M
YoY Change		0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$3.015M
YoY Change		0.0%
Treasury Stock Shares		284.5K shares
Shareholders Equity	$232.4M	$200.9M	$200.9M
YoY Change
Total Liabilities & Shareholders Equity	$2.136B	$2.078B	$2.078B
YoY Change	2.8%	23.62%	23.62%

Cashflow Statement

Concept	2021	2020 Q4	2020
OPERATING ACTIVITIES
Net Income	$40.76M	$8.130M	$28.43M
YoY Change	43.38%	7.68%	-4.74%
Depreciation, Depletion And Amortization	$687.0K	$160.0K	$586.0K
YoY Change	17.24%	45.45%	35.96%
Cash From Operating Activities	$38.64M	$14.03M	$36.52M
YoY Change	5.82%	52.5%	6.05%
INVESTING ACTIVITIES
Capital Expenditures	$64.00K	-$10.00K	$251.0K
YoY Change	-74.5%	-96.55%	-57.74%
Acquisitions
YoY Change
Other Investing Activities	$79.25M	$11.60M	-$133.5M
YoY Change	-159.35%	-126.75%	-23.93%
Cash From Investing Activities	$79.19M	$11.59M	-$133.8M
YoY Change	-159.19%	-126.54%	-24.04%
FINANCING ACTIVITIES
Cash Dividend Paid	$7.600M		$7.400M
YoY Change	2.7%		13.85%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$20.12M	-9.740M	$364.3M
YoY Change	-94.48%	-113.09%	103.68%
NET CHANGE
Cash From Operating Activities	$38.64M	14.03M	$36.52M
Cash From Investing Activities	$79.19M	11.59M	-$133.8M
Cash From Financing Activities	$20.12M	-9.740M	$364.3M
Net Change In Cash	$138.0M	15.88M	$267.0M
YoY Change	-48.33%	-60.22%	618.96%
FREE CASH FLOW
Cash From Operating Activities	$38.64M	$14.03M	$36.52M
Capital Expenditures	$64.00K	-$10.00K	$251.0K
Free Cash Flow	$38.58M	$14.04M	$36.27M
YoY Change	6.37%	47.95%	7.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001315399
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	pkbk	Numberof Projected Future Quartersthe Financialsofthe Borrowers Under Review NumberofProjectedFutureQuarterstheFinancialsoftheBorrowersUnderReview	P1Y
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	000-51338
CY2021	dei	Entity Registrant Name EntityRegistrantName	PARKE BANCORP, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NJ
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	65-1241959
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	601 Delsea Drive
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Washington Township
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08080
CY2021	dei	City Area Code CityAreaCode	856
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Local Phone Number LocalPhoneNumber	256-2500
CY2021	dei	Security12b Title Security12bTitle	Common Stock, $0.10 par value
CY2021	dei	Trading Symbol TradingSymbol	PKBK
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	193900000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11907641	shares
CY2021	dei	Auditor Name AuditorName	RSM US LLP
CY2021	dei	Auditor Location AuditorLocation	Blue Bell, Pennsylvania
CY2021Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	25321000	USD
CY2020Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	20571000	USD
CY2021Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	571232000	USD
CY2020Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	438030000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	596553000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	458601000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	13351000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	19882000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	10025000	USD
CY2020Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	1530000	USD
CY2021Q4	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss	9918000	USD
CY2020Q4	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss	1224000	USD
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	23269000	USD
CY2020Q4	us-gaap	Marketable Securities MarketableSecurities	21106000	USD
CY2021Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	0	USD
CY2020Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	200000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1484847000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1565807000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	29845000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	29698000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1455002000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	1536109000	USD
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	7681000	USD
CY2020Q4	us-gaap	Interest Receivable InterestReceivable	8772000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6265000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6698000	USD
CY2021Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	5144000	USD
CY2020Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	7542000	USD
CY2021Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	27577000	USD
CY2020Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	27002000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7608000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8611000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	7346000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	3681000	USD
CY2021Q4	us-gaap	Assets Assets	2136445000	USD
CY2020Q4	us-gaap	Assets Assets	2078322000	USD
CY2021Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	553810000	USD
CY2020Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	428860000	USD
CY2021Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	1214600000	USD
CY2020Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	1163583000	USD
CY2021Q4	us-gaap	Deposits Deposits	1768410000	USD
CY2020Q4	us-gaap	Deposits Deposits	1592443000	USD
CY2021Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	78150000	USD
CY2020Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	134650000	USD
CY2021Q4	pkbk	Federal Reserve Board Advances FederalReserveBoardAdvances	0	USD
CY2020Q4	pkbk	Federal Reserve Board Advances FederalReserveBoardAdvances	90026000	USD
CY2021Q4	us-gaap	Subordinated Debt SubordinatedDebt	42732000	USD
CY2020Q4	us-gaap	Subordinated Debt SubordinatedDebt	42542000	USD
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1603000	USD
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2338000	USD
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	13189000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	13726000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	1904084000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1875725000	USD
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2020Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	445	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	480	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	445000	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	480000	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12182081	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12136567	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1218000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1214000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	135451000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	134989000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	98017000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	66794000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	245000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	463000	USD
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	284522	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	284522	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3015000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3015000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	232361000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	200925000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	0	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	1672000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	232361000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	202597000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2136445000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2078322000	USD
CY2021	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	80643000	USD
CY2020	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	82336000	USD
CY2021	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	753000	USD
CY2020	us-gaap	Other Interest And Dividend Income OtherInterestAndDividendIncome	1008000	USD
CY2021	pkbk	Interest On Federal Funds Sold And Cash Equivalents InterestOnFederalFundsSoldAndCashEquivalents	676000	USD
CY2020	pkbk	Interest On Federal Funds Sold And Cash Equivalents InterestOnFederalFundsSoldAndCashEquivalents	1194000	USD
CY2021	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	82072000	USD
CY2020	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	84538000	USD
CY2021	us-gaap	Interest Expense Deposits InterestExpenseDeposits	9754000	USD
CY2020	us-gaap	Interest Expense Deposits InterestExpenseDeposits	17711000	USD
CY2021	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	3202000	USD
CY2020	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	4182000	USD
CY2021	us-gaap	Interest Expense InterestExpense	12956000	USD
CY2020	us-gaap	Interest Expense InterestExpense	21893000	USD
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	69116000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	62645000	USD
CY2021	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	500000	USD
CY2020	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	7646000	USD
CY2021	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	68616000	USD
CY2020	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	54999000	USD
CY2021	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	5662000	USD
CY2020	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	2521000	USD
CY2021	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	1346000	USD
CY2020	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	860000	USD
CY2021	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	575000	USD
CY2020	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	592000	USD
CY2021	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	214000	USD
CY2020	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	0	USD
CY2021	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	60000	USD
CY2020	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-371000	USD
CY2021	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	942000	USD
CY2020	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	581000	USD
CY2021	us-gaap	Noninterest Income NoninterestIncome	8799000	USD
CY2020	us-gaap	Noninterest Income NoninterestIncome	4183000	USD
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	9731000	USD
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	10611000	USD
CY2020	us-gaap	Occupancy Net OccupancyNet	2031000	USD
CY2021	us-gaap	Professional Fees ProfessionalFees	3724000	USD
CY2020	us-gaap	Professional Fees ProfessionalFees	1987000	USD
CY2021	us-gaap	Occupancy Net OccupancyNet	2381000	USD
CY2021	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1306000	USD
CY2020	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1290000	USD
CY2021	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	1104000	USD
CY2020	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	805000	USD
CY2021	pkbk	Other Real Estate Owned Expenses OtherRealEstateOwnedExpenses	287000	USD
CY2020	pkbk	Other Real Estate Owned Expenses OtherRealEstateOwnedExpenses	271000	USD
CY2021	us-gaap	Other Noninterest Expense OtherNoninterestExpense	3970000	USD
CY2020	us-gaap	Other Noninterest Expense OtherNoninterestExpense	3301000	USD
CY2021	us-gaap	Noninterest Expense NoninterestExpense	22503000	USD
CY2020	us-gaap	Noninterest Expense NoninterestExpense	20296000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	54912000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	38886000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13937000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10011000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	40975000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	28875000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	215000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	447000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	40760000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	28428000	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	28000	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	29000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	40732000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28399000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.43
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.40
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.36
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.37
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11888429	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11888429	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11850223	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12120716	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11989608	shares
CY2021	us-gaap	Profit Loss ProfitLoss	40975000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	28875000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-294000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	537000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-76000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	132000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-218000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	405000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	40757000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	29280000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	215000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	446000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	40542000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	28833000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	179424000	USD
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	594000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	28875000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	405000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	265000	USD
CY2020	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	3000	USD
CY2020	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	29000	USD
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	5746000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	202597000	USD
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1887000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	40975000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	201000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-218000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	230000	USD
CY2021	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	28000	USD
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	9509000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	232361000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	40975000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	28875000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	687000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	586000	USD
CY2021	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	500000	USD
CY2020	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	7646000	USD
CY2021	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	575000	USD
CY2020	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	592000	USD
CY2021	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	214000	USD
CY2020	us-gaap	Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable	0	USD
CY2021	pkbk	Payments For Origination Of Loans Held For Sale PaymentsForOriginationOfLoansHeldForSale	1650000	USD
CY2020	pkbk	Payments For Origination Of Loans Held For Sale PaymentsForOriginationOfLoansHeldForSale	0	USD
CY2021	us-gaap	Proceeds From Sale And Collection Of Loans Heldforsale ProceedsFromSaleAndCollectionOfLoansHeldforsale	1864000	USD
CY2020	us-gaap	Proceeds From Sale And Collection Of Loans Heldforsale ProceedsFromSaleAndCollectionOfLoansHeldforsale	0	USD
CY2021	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	60000	USD
CY2020	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-371000	USD
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-40000	USD
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-45000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	230000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	265000	USD
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1079000	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	2295000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1059000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1875000	USD
CY2021	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-3176000	USD
CY2020	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	3491000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	38641000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	36517000	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	6139000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	7166000	USD
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Mbs ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesMBS	57000	USD
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Mbs ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesMBS	0	USD
CY2021	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	8693000	USD
CY2020	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	USD
CY2021	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	78996000	USD
CY2020	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	144817000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	251000	USD
CY2021	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	356000	USD
CY2020	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	4217000	USD
CY2021	pkbk	Proceeds From Purchase Of Restricted Stock ProceedsFromPurchaseOfRestrictedStock	2398000	USD
CY2020	pkbk	Proceeds From Purchase Of Restricted Stock ProceedsFromPurchaseOfRestrictedStock	-102000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	79189000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-133787000	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7633000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7444000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	201000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Subordinated Long Term Debt ProceedsFromIssuanceOfSubordinatedLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Subordinated Long Term Debt ProceedsFromIssuanceOfSubordinatedLongTermDebt	29052000	USD
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1887000	USD
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	594000	USD
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	-56500000	USD
CY2020	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2021	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	-90026000	USD
CY2020	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	90026000	USD
CY2021	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	124950000	USD
CY2020	us-gaap	Net Change Noninterest Bearing Deposits Domestic NetChangeNoninterestBearingDepositsDomestic	169591000	USD
CY2021	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	51017000	USD
CY2020	us-gaap	Net Change Interest Bearing Deposits Domestic NetChangeInterestBearingDepositsDomestic	83633000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20122000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	364264000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	137952000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	266994000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	458601000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191607000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	596553000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	458601000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	13691000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	21815000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	16808000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	9360000	USD
CY2021	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	1811000	USD
CY2020	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	0	USD
CY2021	us-gaap	Operations Commenced Date1 OperationsCommencedDate1	1999-01-28
CY2021	pkbk	Number Of Additional Branch Office Locations NumberOfAdditionalBranchOfficeLocations	7	branch
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	USD
CY2021	pkbk	Minimum Period For A Loan Past Due To Be Classified Under Non Accrual Status MinimumPeriodForALoanPastDueToBeClassifiedUnderNonAccrualStatus	P90D
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Concentration of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company’s loans are generally to customers in Southern New Jersey and the Philadelphia area of Pennsylvania. Loans to general building contractors, general merchandise stores, restaurants, motels, warehouse space, and real estate ventures (including construction loans) constitute a majority of commercial loans. The concentrations of credit </span>by type of loan are set forth in Note 4. Generally, loans are collateralized by assets of the borrower and are expected to be repaid from the borrower’s cash flow or proceeds from the sale of selected assets of the borrower.
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	0	USD
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Our most significant estimates pertain to our allowances for loan and lease losses, fair value measurements, the carrying value of OREO, and the valuation of deferred income taxes. Actual results may differ from the estimates and the differences may be material to the consolidated financial statements.</span>
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-294000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	537000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-76000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	132000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-218000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	405000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	40732000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28399000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11888429	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11888429	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11850223	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.43
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.40
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	40732000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	28399000	USD
CY2021	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	28000	USD
CY2020	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	29000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	40760000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	28428000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11888429	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11888429	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11850223	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	232287	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	139385	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12120716	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11989608	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.36
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.37
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	13021000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	372000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	42000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	13351000	USD
CY2021Q4	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss	9918000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	241000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	134000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	10025000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	19258000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	647000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	23000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	19882000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	10000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	9000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	610000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	611000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	7223000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	7388000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	5178000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	5343000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	13021000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	13351000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	0	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	0	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	0	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	0	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount	1283000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities After Five Through Ten Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1524000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities After Ten Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount	8635000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities After Ten Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue	8501000	USD
CY2021Q4	us-gaap	Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss	9918000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	10025000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	168000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	1418000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	41000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	1586000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	42000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	8501000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	134000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2021Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2021Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue	8501000	USD
CY2021Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	134000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	2142000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	20000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	215000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	3000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	2357000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	23000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1480000000	USD
CY2021Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	0	USD
CY2021Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1700000	USD
CY2020Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	-400000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1484847000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1565807000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1484847000	USD
CY2021Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1565807000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	29698000	USD
CY2021	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	427000	USD
CY2021	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	74000	USD
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	500000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	29845000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	591000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	29254000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	29845000	USD
CY2021Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	10302000	USD
CY2021Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1474545000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1484847000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21811000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	59000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	300000	USD
CY2020	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	7646000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	29698000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	1004000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	28694000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	29698000	USD
CY2020Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	22663000	USD
CY2020Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1543144000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1565807000	USD
CY2021	pkbk	Minimum Period For A Loan Past Due To Be Classified Under Non Accrual Status MinimumPeriodForALoanPastDueToBeClassifiedUnderNonAccrualStatus	P90D
CY2021Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	3093000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	3227000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	7209000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	11934000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	591000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	10302000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	15161000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	591000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	3913000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	3913000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	18750000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	23247000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1004000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	22663000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	27160000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1004000	USD
CY2021	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	10282000	USD
CY2021	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	407000	USD
CY2020	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	23798000	USD
CY2020	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	790000	USD
CY2021Q4	pkbk	Performing Tdrs PerformingTdrs	6000000.0	USD
CY2020Q4	pkbk	Performing Tdrs PerformingTdrs	13900000	USD
CY2021Q4	pkbk	Nonperforming Tdrs NonperformingTdrs	0	USD
CY2020Q4	pkbk	Nonperforming Tdrs NonperformingTdrs	274000	USD
CY2020	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0	loan
CY2021	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0	loan
CY2021	pkbk	Current Payment History Of Loan To Determine Loan Should Accrue Interest CurrentPaymentHistoryOfLoanToDetermineLoanShouldAccrueInterest	P6M
CY2021Q4	pkbk	Allowances For Performing Tdrs AllowancesForPerformingTdrs	254000	USD
CY2020Q4	pkbk	Allowances For Performing Tdrs AllowancesForPerformingTdrs	420000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1484847000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	1565807000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	10942000	USD
CY2021	us-gaap	Loans And Leases Receivable Related Parties Additions LoansAndLeasesReceivableRelatedPartiesAdditions	499000	USD
CY2021	us-gaap	Loans And Leases Receivable Related Parties Proceeds LoansAndLeasesReceivableRelatedPartiesProceeds	3159000	USD
CY2021Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	8282000	USD
CY2021Q4	us-gaap	Pledged Financial Instruments Not Separately Reported Loans Receivable Pledged For Federal Home Loan Bank Debt PledgedFinancialInstrumentsNotSeparatelyReportedLoansReceivablePledgedForFederalHomeLoanBankDebt	751100000	USD
CY2020Q4	us-gaap	Pledged Financial Instruments Not Separately Reported Loans Receivable Pledged For Federal Home Loan Bank Debt PledgedFinancialInstrumentsNotSeparatelyReportedLoansReceivablePledgedForFederalHomeLoanBankDebt	703500000	USD
CY2021Q4	us-gaap	Other Real Estate And Foreclosed Assets OtherRealEstateAndForeclosedAssets	1700000	USD
CY2020Q4	us-gaap	Other Real Estate And Foreclosed Assets OtherRealEstateAndForeclosedAssets	139000	USD
CY2021	us-gaap	Other Real Estate Period Increase Decrease OtherRealEstatePeriodIncreaseDecrease	1500000	USD
CY2021Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	1	property
CY2021	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	356000	USD
CY2021	pkbk	Gains Losses On Sales Of Real Estate GainsLossesOnSalesOfRealEstate	60000	USD
CY2020	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	4200000	USD
CY2020	pkbk	Gains Losses On Sales Of Real Estate GainsLossesOnSalesOfRealEstate	-331000	USD
CY2021	pkbk	Write Down Of Real Estate Carrying Values Net WriteDownOfRealEstateCarryingValuesNet	0	USD
CY2020	pkbk	Write Down Of Real Estate Carrying Values Net WriteDownOfRealEstateCarryingValuesNet	40000	USD
CY2021	pkbk	Other Real Estate Owned Expenses Net Of Related Income OtherRealEstateOwnedExpensesNetOfRelatedIncome	287000	USD
CY2020	pkbk	Other Real Estate Owned Expenses Net Of Related Income OtherRealEstateOwnedExpensesNetOfRelatedIncome	271000	USD
CY2020Q4	us-gaap	Other Real Estate And Foreclosed Assets OtherRealEstateAndForeclosedAssets	139000	USD
CY2019Q4	us-gaap	Other Real Estate And Foreclosed Assets OtherRealEstateAndForeclosedAssets	4727000	USD
CY2021	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	1811000	USD
CY2020	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	0	USD
CY2021	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	356000	USD
CY2020	us-gaap	Other Real Estate Disposals OtherRealEstateDisposals	4217000	USD
CY2021	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	-60000	USD
CY2020	us-gaap	Other Real Estate Valuation Adjustments OtherRealEstateValuationAdjustments	371000	USD
CY2021Q4	us-gaap	Other Real Estate And Foreclosed Assets OtherRealEstateAndForeclosedAssets	1654000	USD
CY2020Q4	us-gaap	Other Real Estate And Foreclosed Assets OtherRealEstateAndForeclosedAssets	139000	USD
CY2021Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	553810000	USD
CY2020Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	428860000	USD
CY2021Q4	us-gaap	Interest Bearing Domestic Deposit Checking InterestBearingDomesticDepositChecking	93189000	USD
CY2020Q4	us-gaap	Interest Bearing Domestic Deposit Checking InterestBearingDomesticDepositChecking	66506000	USD
CY2021Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	348427000	USD
CY2020Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	313142000	USD
CY2021Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	179238000	USD
CY2020Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	116605000	USD
CY2021Q4	pkbk	Time Deposits250000 Or More TimeDeposits250000OrMore	163916000	USD
CY2020Q4	pkbk	Time Deposits250000 Or More TimeDeposits250000OrMore	122481000	USD
CY2021Q4	pkbk	Other Time Deposits OtherTimeDeposits	420710000	USD
CY2020Q4	pkbk	Other Time Deposits OtherTimeDeposits	473797000	USD
CY2021Q4	pkbk	Interest Bearing Deposit Brokered InterestBearingDepositBrokered	9120000	USD
CY2020Q4	pkbk	Interest Bearing Deposit Brokered InterestBearingDepositBrokered	71052000	USD
CY2021Q4	us-gaap	Deposits Deposits	1768410000	USD
CY2020Q4	us-gaap	Deposits Deposits	1592443000	USD
CY2021Q4	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	466442000	USD
CY2021Q4	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	58259000	USD
CY2021Q4	us-gaap	Time Deposit Maturities Year Three TimeDepositMaturitiesYearThree	35737000	USD
CY2021Q4	us-gaap	Time Deposit Maturities Year Four TimeDepositMaturitiesYearFour	13115000	USD
CY2021Q4	us-gaap	Time Deposit Maturities Year Five TimeDepositMaturitiesYearFive	20193000	USD
CY2021Q4	us-gaap	Time Deposits TimeDeposits	593746000	USD
CY2021	us-gaap	Interest Expense Domestic Deposit Liabilities Notice Of Withdrawal InterestExpenseDomesticDepositLiabilitiesNoticeOfWithdrawal	324000	USD
CY2020	us-gaap	Interest Expense Domestic Deposit Liabilities Notice Of Withdrawal InterestExpenseDomesticDepositLiabilitiesNoticeOfWithdrawal	328000	USD
CY2021	us-gaap	Interest Expense Domestic Deposit Liabilities Money Market InterestExpenseDomesticDepositLiabilitiesMoneyMarket	2140000	USD
CY2020	us-gaap	Interest Expense Domestic Deposit Liabilities Money Market InterestExpenseDomesticDepositLiabilitiesMoneyMarket	3670000	USD
CY2021	us-gaap	Interest Expense Domestic Deposit Liabilities Savings InterestExpenseDomesticDepositLiabilitiesSavings	664000	USD
CY2020	us-gaap	Interest Expense Domestic Deposit Liabilities Savings InterestExpenseDomesticDepositLiabilitiesSavings	711000	USD
CY2021	us-gaap	Interest Expense Domestic Deposit Liabilities Time Deposit InterestExpenseDomesticDepositLiabilitiesTimeDeposit	6398000	USD
CY2020	us-gaap	Interest Expense Domestic Deposit Liabilities Time Deposit InterestExpenseDomesticDepositLiabilitiesTimeDeposit	11016000	USD
CY2021	us-gaap	Interest Expense Domestic Deposit Liabilities Brokered InterestExpenseDomesticDepositLiabilitiesBrokered	228000	USD
CY2020	us-gaap	Interest Expense Domestic Deposit Liabilities Brokered InterestExpenseDomesticDepositLiabilitiesBrokered	1986000	USD
CY2021	us-gaap	Interest Expense Deposits InterestExpenseDeposits	9754000	USD
CY2020	us-gaap	Interest Expense Deposits InterestExpenseDeposits	17711000	USD
CY2021Q4	pkbk	Lessee Operating Lease Number Of Retail Branches LesseeOperatingLeaseNumberOfRetailBranches	3	branch
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12220000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12155000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5955000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5457000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6265000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6698000	USD
CY2021	pkbk	Depreciation And Amortization Expense Property Plant And Equipment DepreciationAndAmortizationExpensePropertyPlantAndEquipment	496000	USD
CY2020	pkbk	Depreciation And Amortization Expense Property Plant And Equipment DepreciationAndAmortizationExpensePropertyPlantAndEquipment	498000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P5Y
CY2021	pkbk	Lessee Operating Lease Land Lease Remaining Lease Term LesseeOperatingLeaseLandLeaseRemainingLeaseTerm	P84Y
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	26900000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	24900000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2100000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P57Y8M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0739
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2062000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2062000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	290000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	250000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	262000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	262000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	188000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	25688000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	26940000	USD
CY2021Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.16
CY2021Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.16
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.16
CY2021Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.16
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	7600000	USD
CY2020	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	307000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.29
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.20
CY2020Q4	pkbk	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value Per Share ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValuePerShare	1.76
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0060
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6521
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0485
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	602335	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.87
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	270676	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.80
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	307000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	12.29
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	49048	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	7.81
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	176	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	7.81
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	20826	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	12.91
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2233	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.81
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Other Increases Decreases In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Other Increases Decreases In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod	27068	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	532461	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.34
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	602335	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.87
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	282700	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	13.79
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	422646	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	13.43
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	249761	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.83
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	179689	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.55
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	516600	USD
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2000000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4000000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	719600	USD
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1000000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2300000	USD
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	28000	USD
CY2020	us-gaap	Dividends Preferred Stock DividendsPreferredStock	29000	USD
CY2021	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	15
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9906000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9648000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2952000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2658000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	12858000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	12306000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1079000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2295000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13937000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10011000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	7398000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	7255000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	1512000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	1583000	USD
CY2021Q4	pkbk	Deferred Tax Assets Capitalized Other Real Estate Owned Expense DeferredTaxAssetsCapitalizedOtherRealEstateOwnedExpense	0	USD
CY2020Q4	pkbk	Deferred Tax Assets Capitalized Other Real Estate Owned Expense DeferredTaxAssetsCapitalizedOtherRealEstateOwnedExpense	158000	USD
CY2021Q4	pkbk	Deferred Tax Assets Non Accrued Interest DeferredTaxAssetsNonAccruedInterest	79000	USD
CY2020Q4	pkbk	Deferred Tax Assets Non Accrued Interest DeferredTaxAssetsNonAccruedInterest	612000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	167000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	117000	USD
CY2021Q4	pkbk	Deferred Tax Assets Write Down On Partnership Investment DeferredTaxAssetsWriteDownOnPartnershipInvestment	135000	USD
CY2020Q4	pkbk	Deferred Tax Assets Write Down On Partnership Investment DeferredTaxAssetsWriteDownOnPartnershipInvestment	133000	USD
CY2021Q4	pkbk	Deferred Tax Assets Ppp Deferred Loan Fees DeferredTaxAssetsPPPDeferredLoanFees	185000	USD
CY2020Q4	pkbk	Deferred Tax Assets Ppp Deferred Loan Fees DeferredTaxAssetsPPPDeferredLoanFees	509000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	61000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	84000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9537000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	10451000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	135000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	133000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9402000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	10318000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	107000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	158000	USD
CY2021Q4	pkbk	Deferred Tax Liabilities Partnership Income DeferredTaxLiabilitiesPartnershipIncome	35000	USD
CY2020Q4	pkbk	Deferred Tax Liabilities Partnership Income DeferredTaxLiabilitiesPartnershipIncome	28000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	85000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	161000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	1567000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	1360000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1794000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1707000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7608000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	8611000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	11531000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	8166000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2372000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1783000	USD
CY2021	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	46000	USD
CY2020	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	94000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	15000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	11000	USD
CY2021	pkbk	Effective Income Tax Rate Reconciliation Bank Owned Life Insurance EffectiveIncomeTaxRateReconciliationBankOwnedLifeInsurance	121000	USD
CY2020	pkbk	Effective Income Tax Rate Reconciliation Bank Owned Life Insurance EffectiveIncomeTaxRateReconciliationBankOwnedLifeInsurance	124000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-94000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	8000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	87000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	125000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	215000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	166000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13937000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10011000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13900000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	54900000	USD
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.254
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	38900000	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.257
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.03
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	222000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	238000	USD
CY2021	us-gaap	Loans And Leases Receivable Commitments Fixed Rates LoansAndLeasesReceivableCommitmentsFixedRates	70600000	USD
CY2021	dei	Auditor Firm AuditorFirmId	49

Files In Submission

Name	View Source	Status
0001315399-22-000039-index-headers.html	Edgar Link	pending
0001315399-22-000039-index.html	Edgar Link	pending
0001315399-22-000039.txt	Edgar Link	pending
0001315399-22-000039-xbrl.zip	Edgar Link	pending
a2021consentofindependentr.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pkbk-20211231.htm	Edgar Link	pending
pkbk-20211231.xsd	Edgar Link	pending
pkbk-20211231_cal.xml	Edgar Link	unprocessable
pkbk-20211231_def.xml	Edgar Link	unprocessable
pkbk-20211231_htm.xml	Edgar Link	completed
pkbk-20211231_lab.xml	Edgar Link	unprocessable
pkbk-20211231_pre.xml	Edgar Link	unprocessable
pkbk-q4x12312021ex21.htm	Edgar Link	pending
pkbk-q4x12312021ex311.htm	Edgar Link	pending
pkbk-q4x12312021ex312.htm	Edgar Link	pending
pkbk-q4x12312021ex32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PKBK
PARKE BANCORP, INC. Stock $pkbk

2021 Form 10-K Financial Statement

#000131539922000039 Filed on March 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PKBK PARKE BANCORP, INC. Stock $pkbk

2021 Form 10-K Financial Statement

#000131539922000039 Filed on March 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PKBK
PARKE BANCORP, INC. Stock $pkbk